WCG
BIIB icon

Weaver Consulting Group’s Biogen BIIB Stock Holding History

Weaver Consulting Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-104
Closed -$30K – 215
2020
Q3 		$30K Hold
104
– – 0.02% 338
2020
Q2 		$28K Sell
104
-178
-63% -$53.5K 0.02% 328
2020
Q1 		$89K Buy
282
+178
+171% +$54K 0.06% 172
2019
Q4 		$24K Sell
104
-18
-15% -$4.99K 0.01% 339
2019
Q3 		$30K Hold
122
– – 0.02% 282
2019
Q2 		$29K Hold
122
– – 0.02% 281
2019
Q1 		$28K Buy
+122
New +$38.4K 0.01% 622

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Weaver Consulting Group's BIIB Position: Q4 2020 in Review

Weaver Consulting Group sold out of Biogen (BIIB) in Q4 2020, closing a stake of 104 shares — an estimated $30K sold.

Weaver Consulting Group first reported a position in BIIB in Q1 2019 and held it in 7 quarters. The position peaked at $89K in Q1 2020. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Weaver Consulting Group reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 104 Biogen shares in Q4 2020, an estimated $30K.
  • Weaver Consulting Group first reported a position in Biogen in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Biogen position peaked at $89K in Q1 2020.
  • 1,062 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.